SunWoo Hong - OliX PharmaceuticalsI VP Director
| 226950 Stock | 16,490 2,060 11.11% |
Insider
SunWoo Hong is VP Director of OliX PharmaceuticalsInc
| Age | 48 |
| Phone | 82 3 1779 8400 |
| Web | http://www.olixpharma.com |
OliX PharmaceuticalsI Management Efficiency
The company has return on total asset (ROA) of (0.164) % which means that it has lost $0.164 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (76.6277) %, meaning that it generated substantial loss on money invested by shareholders. OliX PharmaceuticalsI's management efficiency ratios could be used to measure how well OliX PharmaceuticalsI manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Kyuwan Kim | ALTEOGEN | N/A | |
| DongHo Woo | Celltrion Pharm | N/A | |
| Jae Jung | ABL Bio | N/A | |
| SangMee Lee | ALTEOGEN | N/A | |
| JongDae Yoo | Celltrion Pharm | N/A | |
| Jaecheon Lee | ABL Bio | N/A | |
| SoonJae Park | ALTEOGEN | N/A | |
| Jong Won | ABL Bio | N/A | |
| Wang Lee | Celltrion Pharm | 63 | |
| Jungsu Seo | Celltrion Pharm | N/A | |
| KwanDeok Jang | Kmw Inc | 65 | |
| You WeonKyoo | ABL Bio | N/A | |
| Seung Lee | ALTEOGEN | N/A | |
| TaeYon JD | ALTEOGEN | N/A | |
| Yeong Yoo | Celltrion Pharm | 53 | |
| EunSuk Choi | Celltrion Pharm | N/A | |
| DukYong Kim | Kmw Inc | 66 | |
| Hang Kim | ALTEOGEN | N/A | |
| Jong Kim | ABL Bio | N/A | |
| Vivek MBA | ALTEOGEN | N/A | |
| HyukJin Gwon | Celltrion Pharm | N/A | |
Management Performance
| Return On Equity | -76.63 | |||
| Return On Asset | -0.16 |
OliX PharmaceuticalsInc Management Team
Elected by the shareholders, the OliX PharmaceuticalsI's board of directors comprises two types of representatives: OliX PharmaceuticalsI inside directors who are chosen from within the company, and outside directors, selected externally and held independent of OliX. The board's role is to monitor OliX PharmaceuticalsI's management team and ensure that shareholders' interests are well served. OliX PharmaceuticalsI's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, OliX PharmaceuticalsI's outside directors are responsible for providing unbiased perspectives on the board's policies.
| SunWoo Hong, VP Director | ||
| Shin Park, Sr Devel | ||
| DongKi Lee, CEO Director |
OliX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is OliX PharmaceuticalsI a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -76.63 | |||
| Return On Asset | -0.16 | |||
| Operating Margin | (6.56) % | |||
| Current Valuation | 576.53 B | |||
| Shares Outstanding | 6.51 M | |||
| Shares Owned By Insiders | 29.21 % | |||
| Shares Owned By Institutions | 6.02 % | |||
| Price To Sales | 75.58 X | |||
| Revenue | 3.67 B | |||
| Gross Profit | 2.42 B |
Pair Trading with OliX PharmaceuticalsI
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if OliX PharmaceuticalsI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OliX PharmaceuticalsI will appreciate offsetting losses from the drop in the long position's value.Moving together with OliX Stock
Moving against OliX Stock
The ability to find closely correlated positions to OliX PharmaceuticalsI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace OliX PharmaceuticalsI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back OliX PharmaceuticalsI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling OliX PharmaceuticalsInc to buy it.
The correlation of OliX PharmaceuticalsI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as OliX PharmaceuticalsI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if OliX PharmaceuticalsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for OliX PharmaceuticalsI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Other Information on Investing in OliX Stock
OliX PharmaceuticalsI financial ratios help investors to determine whether OliX Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in OliX with respect to the benefits of owning OliX PharmaceuticalsI security.